Skip to main content
. 2021 Mar 3;41(5):903–909. doi: 10.1007/s00296-021-04818-2

Table 1.

Clinical and laboratory findings of patients with IA and COVID-19

Disease, N Systemic manifestations, Ν (%) Ear, nose and throat symptoms, N (%) Respiratory manifestations, N (%) Other manifestations, N (%) Laboratory tests, N (%) Hospitalization, N (%) Outcome
RA:17 Arthralgias, myalgias and low-grade fever 15 (88) Sore throat 3 (18) Olfactory dysfunctions 3 (18) 2 (12) Abdominal pain, diarrhea 2 (12)

High CRP:13 (76)

High ESR:10 (59)

2 (12) Very good
PSA:8

Arthralgias, myalgias 8 (100)

Low grade fever 7 (62.5)

Sore throat 2 (25) Olfactory dysfunctions 1 (12.5) 1 (12.5) Abdominal pain 2 (25)

High CRP:6 (75)

High ESR:3 (37.5)

1 (12.5) Very good
AS:7

Arthralgias, myalgias 6 (86)

Low grade fever 3 (43)

Sore throat 1 (14)

Olfactory dysfunction 2 (29)

None Abdominal pain and diarrhea 2 (29)

High CRP 5 (71)

High ESR 3 (43)

None Very good

IA inflammatory arthritis, N number of patients, % percent, RA rheumatoid arthritis, PSA psoriatic arthritis, AS ankylosing spondylitis, CRP C-reactive protein, ESR erythrocyte sedimentation rate